A Choice with Dual Benefits
Requires a doctor's prescription
控糖減重，雙效合一，重拾健康人生！
Weight Loss Program
Mounjaro | Tirzepatide | Dual GIP/GLP-1 Receptor Agonist | Weight Management
Mounjaro (Tirzepatide)
Mounjaro 滿健樂，雙重腸泌素Tirzepatide，有效控糖減重，助您輕鬆管理第二型糖尿病與體重。
4.9
(1,800 user reviews)
HK$ 3,188.00 HKD
/starting at
Prices vary depending on the dosage and quantity; the final price is subject to the doctor's prescription.
Onset of Action
首次注射後數小時
Form
注射劑
Dosage
每週一次，2.5mg起始至最大15mg
Duration of Effect
一週
Mounjaro (Tirzepatide) is the first GIP and GLP-1 dual receptor agonist approved in Hong Kong, specifically designed to provide excellent blood glucose control for people with type 2 diabetes while effectively promoting weight management. Its unique dual mechanism not only significantly lowers HbA1c but also delivers surgical-level weight loss results, helping you regain your health and confidence.Consult with us today to start a new chapter in your health journey.
Product Advantages
雙重機制
獨特雙重作用，有效穩定血糖，全面改善代謝健康。
有效控糖
顯著降低糖化血色素，助您輕鬆管理糖尿病。
輔助減重
促進飽足感，有效減少體重，改善身體指數。
使用方便
每週一次注射，操作簡單便捷，提升用藥依從性。
Guaranteed Authentic
Express Delivery
Protecting Privacy
